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CHAPTER FIVE 
 
5.0 INTERNATIONAL COMPARISONS ON BIOTECHNOLOGY 
COMMUNICATION STRATEGIES 
 
 
This section discusses biotechnology communication initiatives in the UK, USA, 
Australia, Philippines and Singapore as these countries have a head start in 
biotechnology, and in some cases in science communication. Discussion is based on a 
literature review and in-depth interviews conducted with selected respondents who are 
involved in communicating biotechnology in these countries. All information provided 
in this section is obtained from the respondents, otherwise cited by other references.  
 
It is crucial to be aware of initiatives outside Malaysia to learn from them and adapt 
them to suit the local needs and environment in Malaysia. The reasons for choosing 
these countries have been justified in the Methodology Chapter. Based on the 
comparisons between the literature review and the results of this research, it has been 
observed that there are similarities and differences between Malaysia and the countries 
mentioned in this study in terms of public, scientists and media attitudes. The issues and 
challenges in communicating science in general and biotechnology specifically is a 
global phenomenon, whereas public attitudes may differ from country to country based 
on risk perception, anti-biotechnology activism, ethics and religious principles, and trust 
on regulatory policies. Thus, comparing Malaysia to these countries and benchmarking 
it would lead to the development of a robust biotechnology communication strategy for 
Malaysia, where lessons from other countries could be incorporated. Nevertheless, it 
must be acknowledged that the public hold a complex set of beliefs about biotechnology 
and country-specific factors need to be considered. The findings from this study provide 
the needed information to adapt biotechnology communication strategies in the USA, 
UK, Australia, Singapore and the Philippines for Malaysian context. 
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The respondents interviewed for this section is shown in Table 5.0. 
 
Table 5.0:   Respondents from the UK, USA, Australia, Singapore and Philippines for international 
comparisons 
 
Country Name Organisation Designation/Expertise 
USA Prof. Wayne Parrot University  of Georgia Professor/Plant Biotechnology 
USA Prof. Bruce Chassy  University of Illinois Professor/Food safety 
UK Prof Chris Leaver 
CBE 
University of Oxford Professor/Plant Science 
UK Mark Cantley Directorate General for 
Research 
Advisor/Economics 
Australia i. Dr. Craig Cormick Department of Industry, 
Innovation, Science, 
Research and Tertiary 
Education, Australia 
Manager of Public 
Awareness/Journalism & 
Science communication 
Australia ii. Belinda Griffiths Victorian AgriBiosciences 
Centre 
Education Manager/Science 
Communication 
Singapore iii. Prof. Paul Teng Nanyang Technological 
University 
Professor/Crop Biotechnology 
& Policy and Communication 
Singapore iv. Dr. Andrew Powell Asia BioBusiness Consultant/Plant Science & 
Communication 
Philippines v. Dr. Mariechel 
Navarro 
ISAAA Manager/Communication 
Philippines vi. Jenny Panopio Philippines Biotechnology 
Information Centre 
Director/Biotechnology 
 
5.1 THE USA EXPERIENCE 
 
USA is the number one producer of GM crops in the world with a total area of 69 
million hectares (James, 2011) and is a biotechnology leader (Ernst & Young, 2011). 
USA is an example where the level of public acceptance cannot be correlated to the 
level of public understanding of biotechnology. Pew Initiative on Food and 
Biotechnology (PIFB) conducted four major national opinion polls on agricultural 
biotechnology since 2001 (Fink and Rodemeyer, 2007). In 2001, a little more than half 
of Americans reported having seen, read or heard nothing about GM foods (PIFB, 
2001). In 2003 and 2004, the number who have not heard about GM foods had 
increased to more than three-fifths of those responding (PIFB, 2003, 2004), and in 
2005, the polls shows a slight decrease in those saying they had heard little or nothing 
 166 
 
about GM foods (PIFB, 2005). Americans who have seen, read or heard about GM 
foods accounted to 44 per cent in 2001, but, in 2003 and 2004, only 34 and 32 per cent 
respectively, said they have heard something about GM foods (PIFB, 2001, 2003, 
2004). PIFB attributed the drop in awareness to the media’s ever-changing attention to 
GM foods.  
 
In the same poll in 2001, the source named as the most trustworthy was the Food and 
Drug Administration (FDA), with 83 per cent of Americans stating that they trusted 
FDA a great deal (PIFB, 2001). The poll in 2003, again revealed the same result, with 
FDA as the most trustworthy source (PIFB, 2003). These results pointed to “trust” as 
the most important aspect to gain public acceptance on biotechnology and determines 
public attitude. This has been stressed by Priest et. al. (2003) where the authors argued 
that trust functions as an engine of public opinion formation. They further suggested 
that rather than focusing on communication of knowledge to individuals, building trust 
should be primary consideration in understanding public opinion about biotechnology. 
This would serve as an important lesson for Malaysia and it would be highly 
appropriate to incorporate elements of trust in the national biotechnology 
communication framework.  
 
Although there is no National Policy or Strategy for biotechnology communication, the 
1998 Ehlers report had some emphasis in communicating research work to the public. 
The “Communicating Science” section of the 1998 Ehlers report to the U.S. House 
Committee on Science, which recommended congressional actions regarding research 
and science, stated: 
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“Research sponsored by the Federal government should be more readily 
available to the general public, both to inform them and to demonstrate they are 
getting value for the money the government spends on research. Agencies that 
support scientific research have an obligation to explain research to the public 
in clear and concise way.”(House Committee on Science, 1998).  
 
 
However, the impact of this recommendation on public understanding of science is not 
known.  
 
Both the respondents interviewed communicate to the public voluntarily (as many 
scientists in Malaysia) for the reasons as mentioned below: 
“Any researcher who cannot defend his/her work to the public has no business 
doing that research” (Prof. Parrot) 
 
“I believe stakeholders have a right to know why and what we do in science. It 
is a self-serving reason for making sure stakeholders understand science. If they 
do not understand and appreciate what we do, they will no longer support what 
we do.”(Prof. Chassy) 
 
Based on the input provided by the respondents interviewed (Prof. Parrot and Prof 
Chassy), there are neither coordinated efforts at the national level on biotechnology 
communication nor dedicated government agencies to do so. Scientists who are 
personally passionate about promoting biotechnology and enhancing public 
understanding take this responsibility upon themselves voluntarily. Civil society and 
industry organisations such as Bio Industry Organisation (BIO), International Food 
Information Centre (IFIC), CropLife, and Pew are playing a role as well. IFIC’s mission 
is to communicate science-based information on food safety and nutrition to health and 
nutritional professionals, educators, journalists, government officials and others 
providing information to consumers. IFIC also conducts polls on public perception 
towards GM food and this provides useful information to regulators and industry to 
policy making and developing communication strategies respectively. IFIC provides 
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monthly e-newsletter, called FoodInsight to its members, which communicates science-
based food safety and nutrition information. Besides the e-newsletter, IFIC carries out 
primary research on public opinion on food safety and nutrition; reports on the latest 
research on food safety and nutrition in simple language; develop materials and test 
them with consumers and share the results with media and stakeholders in the public 
and private sectors; provide science-based information to the media and refer the media 
to experts in the field; organise conferences and forums that bring diverse stakeholders 
together to share information and improve understanding of nutrition and food safety 
issues (IFIC website). According to both the respondents, IFIC’s initiatives culminates 
into better understanding of biotechnology, especially GM foods among American 
publics.  
 
BIO is another organisation that actively carries out biotechnology communication in 
the USA. It is the world’s largest biotechnology organisation and its mission is to be a 
champion for biotechnology and advocate for its members who are biotechnology 
companies. It provides communication services to its members in the areas of 
agricultural, medical, industrial and environmental biotechnology. BIO organises the 
largest biotechnology event in the world – BIO International Convention annually; and 
like IFIC it also produces an e-newsletter, BIOSmart Brief. The newsletter carries the 
latest information on biotechnology industry, regulations and policies (BIO website). 
According to the respondents, BIO plays an important role in the USA in reaching out 
to the public and also engaging the regulators and policymakers on issues related to 
biotechnology. A similar organisation that could be compared to BIO in Malaysia is 
BiotechCorp as it represents the industry and has been mandated to facilitate the 
development of biotechnology companies in Malaysia. Like BIO, BiotechCorp as 
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discussed under the NRO section, plays an important role both in advocacy and public 
engagement with biotechnology.  
 
There are some National Institutes of Health (NIH) and National Science Foundation 
(NSF) funded educational programmes, mostly directed at medical biotechnology. Both 
respondents agreed that more focus is given to health and medicine than 
agribiotechnology. The target audiences for these programmes are media, doctors and 
consumers, whereas, the agribiotechnology industry directly engages the farmers, 
mainly for the sales of GM seeds.  
“The industry advertises directly to farmers for agribiotech sales and does an 
excellent job of explaining the technology to farmers from a sales perspective. 
(Prof. Chassy) 
 
When asked about the effectiveness of the communication programmes, below were the 
responses: 
“The target audiences are effectively reached, which is why the use of biotech 
crops is so high in the US, and the pharmaceutical industry does well in 
communicating medical sciences related to their products. The rest of the 
population is left out, particularly on agricultural biotechnology” (Prof. Parrot) 
 
“Industry knows how to sell. Doctors understand medical biotech and farmers 
understand agribiotech. I don’t think consumers find the right messages, the 
media could care less what the trust is, and policymakers only care about what 
will get them the most votes and or/political contributions or bargaining power” 
(Prof. Chassy) 
 
 
It is clear that communication programmes are industry-driven with marketing their 
products as the main objectives. However, both respondents said in recent years, a 
portion of NSF, Department of Environment, US Department of Agriculture’s research 
funds must be set aside to communicate science to the public. As these funds are part of 
individual research grants, the communication that takes place depends on the research 
topic of the individual scientist, without any overall coordination on topic or strategy. 
Furthermore, these grants are primarily targeted at school children. The other option 
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taken by scientists to fulfill the communication requirement is by just having a website 
posted. Communication is seen as a burden by scientists who have neither the time nor 
training for it. This seems to be the case in Malaysia, where scientists’ objectives are to 
promote their research and commercialisation. Nevertheless, Malaysian scientists do not 
have an obligation to engage with the public, and their research grants do not have 
allocation for this. This practice could be adopted in Malaysia, but with coordinated 
efforts so a wider range of audience and topics are covered.  
 
The obstacles in communicating biotechnology identified by both the respondents were 
that biotechnology companies have the funds for biotechnology outreach programmes, 
but lack the necessary credibility, whereas, scientists lack the funds and time to engage 
with the public. Another major obstacle is the lack of media support due to anti-
biotechnology stand of most of the editors and journalists and also because scary news 
sells more than positive news. Suggestions provided were to have a pro-biotechnology 
NGO that could convey messages to the public, use of proper channels that would reach 
the public (understanding alternative media such as the internet and the social media),  
incentives for scientists to communicate with the public, and training the media and the 
scientists on communicating biotechnology and engaging with the public 
 
From the responses, observation could be made that Malaysia is not lagging behind the 
USA in terms of biotechnology communication. Although there are similar challenges 
such as lack of coordinated efforts at the national level, scientists’ time for 
communicating, and training for scientists in this area, there is active biotechnology 
awareness programmes in Malaysia by various players as discussed earlier. What could 
be adapted from the USA experience is the allocation of a portion of research grants for 
engagement with the public.  
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5.2 THE UK EXPERIENCE 
 
 
 
The Bodmer Report in 1985 and the setting up of CoPUS in 1988, created a number of 
schemes to promote public understanding and appreciation of science (Bodmer, 1985). 
However, a survey conducted in 1988 among the British public showed only 10 per cent 
or less of those questioned were scientifically literate (Durant et. al. 1989). A follow up 
survey in 1996 indicated little change in scientific literacy, but interest in science 
remained high (Miller, 2001). The reason for the low science literacy among the public 
in spite of the CoPUS initiatives was assumed to be the “deficit model” practiced 
(Gross, 1994). This gave rise to the “contextual approach” which was then practiced 
under the “Science and Society” report by the House of Lord (Miller, 2001).  
 
However, in the case of the UK, public behavior and attitudes towards biotechnology 
and science are not the same where biotechnology, especially GM food is one of the 
most contentious issues. A number of events dramatically changed public opinion about 
GM food (Gaskell et. al., 2001). First, the government’s handling of “mad cow” or 
Bovine Serum Encephalitis (BSE) crisis in late 1980s presented a pivotal issue on food 
safety (Jasanoff, 1997; Durant et. al., 1998).  Second, in the mid-1990s, the launch of 
the Flavr Savr tomatoes was a relative success, in spite of it being clearly labeled as a 
GM product (Robinson, 1997). However, the temporary success did not last and this 
was attributed to the company’s inexperience in marketing and shipping the tomatoes. 
The third event took place in 1996, when the first shipment of Monsanto’s 
RoundupReady soya beans arrived in Europe (Lassen et. al. 2002). NGOs actively 
campaigned, making the mixing of GM and non-GM soya as an issue. This caused a 
heavy-handed response from the industry (Simmons and Weldon, 2000), which was 
interpreted by the public as biotechnology industry showing disdain for consumers 
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(Harvey, 1999).  The fourth event was known as the Pusztai Affair, where Arpad 
Pusztai, a researcher at the Rowett Research Institute in Arberdeen in 1998, claimed on 
UK television that his rat experiments had shown that eating GM potatoes could lead to 
intestinal changes (Poortinga and Pidgeon, 2007). Although the work was then declared 
as unscientific, it brought the potential risks of GM crops to human health to public 
attention. The fifth event was the cloning of Dolly by the Roslin Institute in Edinburgh, 
which sparked an intensive public and media debate about ethics in biotechnology 
(Poortinga and Pidgeon, 2007). All the events above contributed to the GM controversy 
and public rejection towards this technology.  
 
The events that led to public rejection and resistance towards GM technology in the UK 
pointed to element of “trust”, similar to the situation in the USA, although the situation 
in the USA was favourable towards GM technology. These experiences recognise the 
need to incorporate the element of “trust” into communication strategies. This may be 
done by engaging a trusted and highly credible champion (e.g.religious scholars in the 
case of ethical issues), or informing the public of the regulatory processes that are in 
place, and how scientists, industry and regulators conduct risk assessment and risk 
management.  
 
To understand the current situation in the UK, the respondents (Prof. Leaver and Mark 
Cantley) were interviewed for this research. The main agencies involved in 
communicating biotechnology to the public, according to the respondents are the 
National Research Councils and Bioindustry Association. Their target audiences cover a 
wide spectrum – general public, media, students, policymakers, and industry. Each 
respondent felt differently about the effectiveness of the programmes.  
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“Tricky – and often, not very effective. And the NGOs are often opportunist in 
seizing on news events. That makes government’s propaganda 
counterproductive” (Mark Cantley) 
 
“Variable – it depends on which agency, which target and the criteria 
employed. For example the UK media in 2006 was about 2:1 against 
agricultural biotechnology; and since 2007 it has become roughly 2:1 in 
favour.” (Prof. Leaver) 
 
 
According to both the respondents, media plays a major role in providing information to 
the public, but mostly media’s primary information is obtained from anti-biotechnology 
NGOs, especially on agricultural biotechnology. Media in the UK also shapes public 
opinion. Both the respondents agreed that there are broad commitments from the 
government to encourage public understanding of science (including biotechnology), 
but they are not nationally organised. Thus, a National Policy on science 
communication is missing. However, there are a number of players who actively engage 
the public such as British Science Association, the Royal Society, Societies of Biology, 
Biochemical, and General Microbiology.  
 
Both the respondents concurred that there is funding, though limited, allocated for 
science communication, but not particularly for biotechnology. Because of the endless 
on-going debate on biotechnology in the UK and the presence of active anti-
biotechnology NGOs, both respondents felt that more funds should be spent on 
educating young people on the potential of biotechnology. Mark Cantley feels the 
reluctance of scientists to be drawn into public debate has to change.  
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When asked what are the obstacles for effective biotechnology communication in the 
UK, the responses were given as below:  
“A lack of interest and of understanding among the public together with the 
poor quality of scientific understanding among the national leadership: no 
members of the government and almost no Members of Parliament have a 
science degree.” (Prof. Leaver) 
 
“Budgetary constraints, lack of public interest. We should encourage 
individuals – scientists, policymakers, politicians to engage in public debate. 
The media fall back upon a limited group of very doubtful quality and integrity.” 
(Mark Cantley) 
 
Overall, there are many similarities between the UK and Malaysia, such as the 
government’s initiative towards promoting public understanding of 
science/biotechnology. This is seen in the case of BIOTEK, NRE and BiotechCorp in 
Malaysia, where government funds are allocated to engage with the people. A number 
of national institutions undertake public understanding of biotechnology in both 
countries. What is lacking in Malaysia, unlike the UK, is a national strategy to promote 
public understanding of science/biotechnology. Another contrast between the UK and 
Malaysia is that the activism against biotechnology is greater in the UK, though it is 
confined more to agribiotechnology. Public concerns about undesired effects of 
scientific-technological development are particularly pronounced in the European 
Union, including the UK (Lujan and Todt, 2007). Thus, this translates into more 
resistance towards biotechnology among the public in the UK compared to Malaysia. 
This is one of the reasons why EU executive branch, the European Commission, has 
been active in this area, trying to start a dialogue with society on issues related to 
science and technology. One of the first results is the Science and Society Action Plan, 
which aimed at increasing understanding of science among European (European 
Commission, 2001a). Another initiative from the European Commission, The European 
White Paper on governance raises the issue of “democratising expertise”, where the 
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commission expressed the need for more citizen participation in policy making in order 
to increase public trust (European Commission, 2001b). Citizens’ trust in decision-
making processes is now regarded as one of the fundamental pillars of technology 
development (Todt, 2003).  These initiatives are good models for Malaysia to emulate 
and justify the need for a biotechnology communication strategy at the national level.  
Furthermore, the initiatives that came out from Bodmer and Wolfendale reports, which 
saw an increase in the number of scientists engaging with the public could serve as an 
example for Malaysia. Though, Malaysia is spared from crisis such as BSE where the 
trust of the general public is jeopardised, as a number of Malaysian biotechnology 
sectors are in the embryonic stage, this would be the best time to scale up public 
awareness programmes and take proactive role to be ahead of anti-biotechnology 
movements and to enhance public participation in government policies. Malaysia is 
moving in the right direction but a stronger push is needed for a more coordinated effort 
among all players involved.  
 
 
5.3 THE AUSTRALIAN EXPERIENCE 
 
 
Australia has strong biotechnology communication initiatives that are well coordinated 
with industry, research and educational groups working closely with government 
agencies, and this unified message ensures maximum effect with minimal duplication 
(Cormick, 2011). A number of universities have incorporated science communication 
modules into science programmes and offer post-graduate degrees in science 
communication. The Centre for the Public Awareness of Science at the Australian 
National University is one such example (Bryant, 2003). The “Inspiring Australia” 
report (Inspiring Australia, 2010) which was an initiative by the Department of 
Industry, Science, Research and Tertiary Education, proposes a national approach for 
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community engagement with the sciences. This report is expected to complement 
Australia’s Innovation Agenda as a high-quality national strategy for public engagement 
with the sciences and seeks to increase appreciation of science in Australian culture, 
facilitate informed citizen participation in decision making and science policy 
development, boost confidence in the Australian Government’s research investment, 
and ensure a continuing supply of well-qualified science graduates.  
 
Australia has a distinctive programme for politicians to help them better understand the 
role of science in the development of public policy. This has been discussed by Parsons 
(2001) in her paper. Commonwealth Scientific and Industrial Research Organisation 
(CSIRO) initiated the National Awareness Parliamentary Information Program in 
November 1998. This service delivers email information about CSIRO scientific 
advances, whereby the information is individually tailored and sent direct to all 
Members of Parliament. The information can be used by individual Members of 
Parliament and their staff for policy development; inclusion in speeches delivered 
locally or in Parliament; briefings providing advice on current issues; preparing their 
own media releases to local media; and responses to individual inquiries from the 
public.  
 
Another programme reported by Parsons (2001) is the annual Science Meets Parliament 
(SMP) organised by Australia’s Federation of Scientific and Technical Societies 
(FASTS) since 1999, where Federal politicians are invited to meet a pair of scientists 
from their electorate. FASTS had four primary aims: to make politicians more aware of 
what science can do for Australia; to make scientists more knowledgeable about policy 
formulation; to make a favourable impact on both the political process and the budget; 
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and to develop long-term relationships between individual scientists and Members of 
Parliament.  
 
There are a number of organisations, both public and private that are involved in 
communicating biotechnology to various stakeholders in Australia, according to the 
respondents interviewed in this research (Dr. Cormick and Belinda Griffiths). The 
organisations and their target audiences are as below: 
 The Australian Biotechnology Industry Association (AusBiotech): industry and 
the general public 
 
 Australian Stem Cell Network: researchers and the general public  
 
 AgrifoodAwareness Australia (a group funded by industry to provide 
information on agricultural biotechnology): farmers, farmer groups, media, 
politicians, and the general public 
 
 National Enabling Technologies Strategy – Public Awareness and Community 
Engagement (formerly Biotechnology Australia): the general public interest 
groups, teachers, media, influencers 
 
 National Health and Medical Research Council: health professionals, patient 
groups and the active public 
 
 The Commonwealth Scientific and Industrial Research Organisation (CSIRO): 
general publics, industry, media, schools, and politician 
 
 Australian Centre for Functional Plant Genomics (ACPFG): general publics, 
media 
 
 NGOs such as GeneEthics, Greenpeace, The Network of Concerned Farmers 
and the Public Health Association: general publics, media and politicians 
 
 
The effectiveness of the programmes was described by Belinda Griffiths as: 
 
“I would say they are fairly effective at reaching the interested and engaged 
public (people who seek information), moderately effective at reaching the 
interested public (people who don’t seek information but are interested if they 
stumble across it) and not effective at reaching the disinterested, disengaged 
public (people who do not seek information and who actively ignore messages 
about biotechnology from science organisations or the government.”(Belinda 
Griffiths) 
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The Inspiring Report (2010) and the National Enabling Technology Strategies were 
mentioned as the National Science Communication Policy by both the respondents. Dr. 
Cormick described the national strategy as: 
 “Rather than a single national communications strategy, there is a network of 
linked strategies that are coordinated through a national communications group 
that work to coordinate activities into a web that complement each other.”(Dr. 
Cormick) 
 
 
The government allocates funds for biotechnology communication for a number of 
initiatives such as for the National Enabling Technologies Strategies, CSIRO, and 
universities. According to Dr. Cormick, the challenges in biotechnology communication 
in Australia varied according to the field. For GM crops, public are confused by 
misinformation campaigns by some civil societies, largely based on personal values and 
not science. Communication on stem cells has evolved from having a debate with anti-
stem cell advocates on the inherent values in embryonic stem cell uses to dealing with 
issues of over-promising cures that need to be tempered with more realistic promises. 
Synthetic biology suffers from lack of public awareness and understanding, and 
industrial biotechnology’s challenge is to demonstrate how biotechnology could provide 
economic, environmental and societal outcomes while dealing with issues of food-fuel 
imbalances for biofuels. Besides challenges that are subject-specific, generic challenges 
pointed out by Dr. Cormick are: translating the complexity of science to the general 
public; and getting scientists to take part in public debate. 
 
Belinda Griffiths believes media in Australia generally portrays biotechnology in a 
positive light, with a focus on the benefits for human and the environment. However, 
Dr. Cormick felt that the standard of science reporting among Australian journalists is 
slipping in the mainstream media. Nevertheless, there are a number of very good 
science journalists who do excellent job (as there are those who do a poor job).  
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This could be explained as not all media have a strong science unit or science journalist 
team. The Australia Broadcasting Corporation (ABC) Science Unit, the Australian, and 
the Age newspapers have strong science units or science journalists, according to Dr. 
Cormick. Whereas, other smaller media do not have dedicated science journalists and  
biotechnology is often assigned to journalists who cover a very wide range of materials 
and are not readily able to discern good science from pseudoscience. This scenario is 
even worse in Malaysia, where only one newspaper has a dedicated science desk, 
Utusan Malaysia.  
 
On the whole, Australia is further advanced than the other countries in terms of its 
national strategies and approach towards public understanding of science. The 
government is committed towards creating a science-literate society and citizens who 
are able to participate in government policies (Inspiring Australia, 2010). This offers an 
ideal model for Malaysia to emulate.  
 
5.4 THE SINGAPOREAN EXPERIENCE 
 
 
Singapore is Asia’s leading investor in biotechnology, with the government channeling 
US$700 million into biotechnology funds in 2002 (Asia Private Equity Review, 2002), 
with medical and healthcare biotechnology as the biggest sector. However, public 
understanding of biotechnology is not a national priority, according to the two 
respondents interviewed here. There is no national science or biotechnology 
communication policy or strategy. Biotechnology communication programmes are 
currently undertaken by Genetic Modification Advisory Committee (GMAC), through it 
Public Awareness Sub-committee, and the Singapore Science Centre, through its 
exhibits and programmes.  Both these agencies target general public and school 
children.  
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The effectiveness of Singapore Science Centre is not possible to be measured according 
to Prof. Teng, but the centre has thousands of “walk-through” visitors who are exposed 
to its exhibits. GMAC has limited audience exposure, but the committee has prepared 
biotechnology information materials in several languages that are widely distributed, 
but impact assessment has not been carried out. Both respondents were positive about 
the media’s role in covering biotechnology. Dr. Powell said the mainstream media plays 
a significant role in communicating biotechnology, whereas Prof. Teng said: 
“There are irregular articles which are well-researched by the media’s science 
journalists. Media is mainly biotechnology-friendly and reflective of the 
government’s pragmatic approach in promoting biotechnology.”(Prof. Paul 
Teng) 
 
Government funding for public understanding of biotechnology is allocated to the 
Science Centre and GMAC, but no evaluation has been done to measure the 
effectiveness of the communication strategies. Generally, both respondents concurred 
that biotechnology acceptance among the Singaporean public is good and public 
resistance is not an issue. Thus, the need for an active communication programme does 
not seem urgent. This in turn becomes a challenge for a more robust biotechnology 
communication programme in Singapore to enhance public understanding as the current 
low level of communication is sufficient to create the needed acceptance. The 
Singapore situation is similar to the USA where public acceptance does not correlate to 
public understanding of biotechnology. Again, this exemplifies the importance of public 
trust in a biotechnology communication strategy. However, Prof. Teng feels 
improvements could be made to the intensity of activities in communicating the benefits 
of biotechnology by the Science Centre and GMAC, as part of their regular programmes 
to cultivate awareness of biotechnology.  
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It is clear that Singapore’s biotechnology communication programme is driven by the 
need to have public acceptance. The government and scientists might be taking public 
engagement with biotechnology lightly since there is lack of resistance towards the 
technology. However, public awareness and understanding of biotechnology might be 
affected due to this. Prof. Teng suggested identifying key stakeholders who are decision 
makers or potential bottlenecks to biotechnology acceptance and designing an 
intervention pogramme which targets their concerns by using credible parties to 
communicate.  
 
In comparison, Malaysia fares much better in her approaches and initiatives in 
communicating biotechnology to the public than Singapore. Singapore might not be a 
good model to follow, as Malaysia’s public is more heterogeneous and public 
acceptance is not at the optimal level yet. Nevertheless, media in Singapore is more 
supportive to biotechnology which could be emulated in Malaysia. 
 
5.5 THE PHILIPPINES EXPERIENCE 
 
 
The Philippines was the first Asian country to commercialise GM crop when it first 
started to cultivate GM corn in 2002 (Panopio and Navarro, 2011). Juanillo’s (2003) 
survey revealed that stakeholders in the Philippines (scientists, consumers, 
businessmen, policymakers, farmer leaders, extension workers, journalists, and 
religious scholars) had above moderate interest in biotechnology. At least 70 per cent of 
policymakers, businessmen, and extension workers believed that biotechnology would 
contribute positively to the agriculture sector in the Philippines. Another survey was 
conducted by Torres et. al. (2006) after the commercialisation of GM corn, which 
showed that majority of stakeholders had favourable perception towards agricultural 
biotechnology. A survey by the Asian Food Information Centre (AFIC) in 2008 
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indicated that Philippine consumers were knowledgeable and positive about food 
biotechnology. Consumers largely believed that biotechnology crops have the potential 
to deliver high quality and nutritional food. And a large majority indicated that they 
accepted biotechnology as a way to increase food production.  
 
The anti-GMO activities during the commercialisation of GM corn ignited the 
collaboration between academic and government institutions on an information and 
communication campaign on biotechnology in 1998 (Panopio and Navarro, 2011). 
Efforts were geared towards introducing the concepts of biotechnology to the general 
public with the intent of preparing a favourable environment for commercialisation of 
biotechnology products. The establishment of SEAMEO Regional Centre for Graduate 
Study and Research in Agricultural Biotechnology Information Centre (SEARCA BIC) 
in 2000 further boosted the efforts in communicating biotechnology, especially 
agricultural biotechnology.  
 
Jenny Panopio, one of the interviewees named the following agencies as being involved 
in communicating biotechnology to the public: SEARCA BIC, the Biotechnology 
Media Advocacy Resource Centre, the Department of Agriculture, the Department of 
Science and Technology and the National Academy of Science and Technology. This 
draws a similarity to Malaysia where a number of government agencies (NROs) and 
research institutes are involved in engaging with the public on biotechnology. The 
target audiences of these institutes are scientists, journalists, and the general public, 
according to Panopio. Navarro said religious scholars became an important target 
audience when the Catholic churches went against GM crops (between 2001-2003) and 
also when the Muslim scholars in the Philippines declared GM crop as “haram”. 
However, not all programmes are effective due to the limited resources available and 
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the inability to reach the entire country.  Like the UK, misleading information provided 
about biotechnology by NGOs is counterproductive to the programmes carried out by 
scientists. Navarro mentioned the following as the main challenges in the Philippines: 
“Language barriers; need for translation and simplification of information; 
science is not an exciting thing to read unless it deals with issues that directly 
affect readers.”(Dr. Mariechel Navarro) 
 
The media in the Philippines plays an important role, as according to Panopio there is a 
pool of science writers who are active in publishing biotechnology news. However, the 
television and radio are not fully utilised and air limited reports on biotechnology. From 
media monitoring surveys, Navarro observed that the Philippine media generally report 
accurately about biotechnology. Her survey from 2000-2009 on the top three national 
English newspaper (Navarro, 2011) showed the majority of articles published were 
positive (41.3%) and neutral (38.2%). These newspapers published a total of 1,355 
articles on modern crop biotechnology during the ten year period or a yearly average of 
136 articles. Thus, the media is an important tool for biotechnology communication in 
the Philippines. 
 
Although there is no National Science/Biotechnology Communication Policy or 
strategy, the Presidential Proclamation No. 1414 declared the National Biotechnology 
Week as an annual celebration every last week of November. And according to 
Panopio, this activity contributes to biotechnology or science communication in the 
country in terms of raising awareness of the general public.  
“This week involves the various government departments such as the 
Department of Science and Technology. the Department of Agriculture, and the 
Department of Environment and Natural Resources.” (Jenny Panopio) 
 
 
 184 
 
Funding remains an issue according to Panopio and Navarro. Limited funding is 
allocated for the different agencies such as Department of Agriculture and Department 
of Science and Technology.  
“These departments have specific communication programmes for government-
funded biotechnology research.” (Jenny Panopio) 
 
 
The suggestions provided by Panopio and Navarro on improving the current 
communication programmes are: key stakeholders such as media, farmers, and 
policymakers need to be educated on biotechnology; more involvement from the 
scientists; and enhanced collaboration between key agencies.  
 
In conclusion, the Philippines has an active biotechnology communication programme 
with good media support and involvement of key stakeholders. This resembles the 
situation in Malaysia, although media support is not as good as in the Philippines. 
However, the Philippines success in emerging as the first Asian country in 
commercialising GM crop for food and feed without the existence of a national 
biotechnology communication strategy cannot be construed as a good model for 
Malaysia. Unlike the Philippines, Malaysia does not only focus on agribiotechnology, 
but the entire biotechnology spectrum ranging from agriculture, industry, and medical. 
Malaysia has a pressing need to develop its human capital to support its growing 
biotechnology industry (Malaysian Agricultural Biotechnology Sector, 2009; Malaysian 
Medical Biotechnology Sector, 2009; and Malaysian Industrial Biotechnology Sector, 
2009). Besides human capital development, market acceptance, balanced policies and 
regulations, and public participation in business ventures call for a more structured and 
coherent biotechnology communication and public engagement. Due to the huge 
investments of Malaysian government in biotechnology sector the need for a national 
biotechnology communication strategy is justified.  
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5.6 CONCLUSION ON INTERNATIONAL EXPERIENCES 
 
It is seen that communication strategies in each country takes different forms and 
intensity. Australia has the best communication strategies with well coordinated efforts 
at the national level. The UK, too has initiatives at the national level, though there is 
skepticism about its success rate, as shown in surveys on public’s level of science 
understanding (Durant et. al., 1989 and Miller, 2001).  The government’s efforts in 
promoting understanding of science became counterproductive due to the anti-
biotechnology NGOs’ activism, according to the two respondents in this research.  The 
events in 1990s related to GM crops, cloning and BSE too had huge roles to play in 
public perception of biotechnology. The deficit model practiced was also the cause for 
the communication failure (Gross, 1994). One-way late-stage communication models 
have proven ineffective and have only further alienated the very audiences they meant 
to attract (Ireland et. al, 2007). The USA does not have strong public understanding of 
biotechnology initiatives, in spite of its strong biotechnology sector. Scientists 
voluntarily undertake biotechnology communication programmes. However, public 
acceptance towards biotechnology remains high in the USA, mainly due to the trust in 
the government and regulatory bodies. Nevertheless, science literacy among the public 
remain low. In Singapore, given the no-issue situation on public acceptance of 
biotechnology, communicating biotechnology is not a priority in this city state. And 
finally, the Philippines, like the UK has an active biotechnology communication 
programme. Key agencies are involved with the support from the media. This is evident 
from their success in commercialising GM corn and being the first country in Asia to do 
so, in spite of the initial resistance from the civil societies and the general public. 
Taking all the initiatives in these countries into consideration, Malaysia is doing very 
well, in spite of the lack of a national level public understanding of biotechnology  or 
science movement.  
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In making international comparisons, the different culture in terms of public behavior 
and trust on regulatory bodies need to be taken into consideration, as these are the key 
factors that would determine the success and impact of any communication framework. 
In Singapore, for example, the need to have an aggressive biotechnology 
communication programme at the national level is not crucial as the public does not 
have reservation towards government policies and regulations. This is completely the 
opposite for the UK, where a number of events in 1990s eroded public trust on 
regulatory bodies. A strong belief in the benefits of science and technology does not 
mean that individuals have no reservation about the impact of science and technology 
(Miler, 2004). Miller et. al. (1997) investigated the relationship between public 
perceptions of the benefits of science and technology and their concerns about the 
impact of science and technology in Canada, the European Union, Japan and the USA. 
In the USA, individuals who hold a strong belief in the promise or benefits of science 
and technology were significantly less likely to hold a strong reservation about science 
and technology. By contrast, the correlation between these two beliefs in the European 
Union showed that individuals in Europe who held a positive view of the promise of 
science and technology also held moderately strong reservations about the impact of 
science and technology.  
 
The assumption that public objections stem from ignorance has been questioned by 
several researchers.  Priest (2001) reported that the dominant assumption that objections 
to biotechnology necessarily spring from ignorance is a misconception. Data from 
National Science Board (2000) suggests that objections to biotechnology are becoming 
slightly more prevalent among the most educated segment of the USA population. This 
directs the attention to the importance of trust in relevant authorities as a factor that 
determines public acceptance of biotechnology. Judgments about riskiness of new 
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technologies such as bioengineered foods involve judgments about trustworthiness of 
scientists and their employers (Priest, 2001). Thus, public trust is a valuable commodity 
(Priest, 2001) and should be an important component of the biotechnology 
communication framework.  In Malaysia, government is seen as the third credible 
source of information after the media and scientists. Therefore, it could be concluded 
that Malaysia has the right culture for biotechnology literacy to grow, which would then 
lead to public acceptance of the technology.  
 
The comparisons revealed that in spite of Malaysia being a newcomer to the 
biotechnology sector, there is stronger public awareness programmes compared to 
countries like the USA and Singapore. Malaysia is comparable to the UK and the 
Philippines and in fact has advantages over these countries given that Malaysian publics 
are more receptive towards biotechnology (Amin, 2007) as also shown in the survey of 
this research. Nevertheless, Malaysia is lagging behind Australia in terms of a concerted 
national strategy for science communication and in training young graduates during 
their university programmes. Despite the shortcomings, some Malaysian scientists are 
passionate about communicating biotechnology, engaging with the public, and also for 
being trained in this area. This is evident from the inputs provided by the scientists 
interviewed for this research. There are also a number of NROs that carry out 
biotechnology outreach programme. The hurdles in Malaysia such as lack of media 
support, a void in the initiative to train scientists and young science graduates to 
communicate to non-specialists, and lack of dedicated funds for public understanding of 
science or biotechnology could be addressed if there is well-coordinated effort on public 
understanding of biotechnology at the national level like the UK or Australia. Another 
major aspect that is not in place in Malaysia is an evaluation exercise that measures the 
impact of all the biotechnology communication activities. The number of scientists 
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involved in biotechnology communication is also negligent compared to the total 
number of scientists. Given the strong biotechnology policy in place in Malaysia, the 
country cannot be complacent with the current biotechnology communication strategy. 
This is coupled with the dwindling interest in science among its students cited earlier 
from newspaper reports. Thus, the national framework for biotechnology 
communication is still needed to elevate the current practice and to synchronise it. Table 
5.1 compares the biotechnology communication initiatives in the five countries. 
 
Table 5.1: Comparisons between the UK, USA, Australia, Singapore and the Philippines  
 
 UK USA Australia Singapore  Philippines 
Media support Moderate Poor Moderate Good Good 
Funding  Limited Poor  Yes Limited Limited 
National 
Strategy 
Yes No Yes No No 
Agencies 
involved 
Government, 
industry, 
NGOs 
Industry, civil 
societies, 
NGOs 
Government, 
industry, 
universities, 
NGOs 
Government Government, 
NGOs 
NGO activism Active Moderate Active No Active 
Public 
perception 
Negative Moderate Moderate Good Moderate 
 
 
It is important to note that a number of other countries have aggressively moved 
towards science communication programmes with the government setting national level 
strategy. Report by Massarani (2004) on Latin America portrays this region as an 
example where countries have created national science communication plans. One 
successful example is the Explora programme in Chile, created in 1995 by COCNICYT 
(the National Commission for Scientific and Technological Research). Panama is 
another country that has science popularisation programmes, created in 1997. In Brazil 
former President Lula’s science popularisation plan is being implemented now. Proper 
training for science communication has been a constant item on these plans and 
although a number of courses (including masters and PhD courses) have already been 
created at universities and scientific institutions, many feel that there is scope for more. 
 189 
 
In Denmark, an University Act which came into force in May 2003 listed science 
communication as a third obligation for the universities, in addition to research and 
teaching. Danish universities are intended to play an increasing role in communicating 
science which is also the case for many European countries (Nielsen, 2005). Like the 
UK’s Public Understanding of Science (PUS), Germany’s science popularisation effort 
is called “Public Understanding of Science and Humanities (PUSH)” (Schnabel, 2003).  
 
Given the global scenario, it is important for Malaysia to beef up the current 
biotechnology communication strategy. This is discussed in the last Chapter where the 
results from this research form the basis for the biotechnology communication 
framework and strategies for Malaysia.  
 
